Reaction
Autoimmune Myositis reporting signals
As of the last recalculation, Autoimmune Myositis appears in 452 FAERS reports alongside 10 co-occurring drug terms. The strongest observed disproportionality signal is NITROFURANTOIN (PRR 46.3).
Important: FAERS is a spontaneous, voluntary, unverified reporting system. PRR and ROR identify reporting patterns for investigation; they are not incidence rates and do not establish causation.
| Drug | Co-reports | PRR | ROR |
|---|---|---|---|
| Nitrofurantoin | 16 | 46.3 | 46.3 |
| Nitrofurantoin (Monohydrate/Macrocrystals) | 16 | 45.7 | 45.7 |
| Atorvastatin Calcium, Film Coated | 57 | 42.7 | 42.7 |
| Inclisiran | 6 | 34.9 | 34.9 |
| Isosorbide Mononitrate | 15 | 34.4 | 34.4 |
| Durvalumab | 8 | 18.4 | 18.4 |
| Brentuximab Vedotin | 4 | 18.1 | 18.1 |
| Atezolizumab | 14 | 17.1 | 17.1 |
| Nivolumab | 29 | 14.7 | 14.7 |
| Salicylic Acid | 3 | 2.6 | 2.6 |